Primol

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Primol

Property Description
Active Ingredient Ciprofloxacin
Pharmacological Class Fluoroquinolone Antibiotic
Forms Tablet, Suspension, IV Solution, Eye/Ear Drops
General Purpose Bacterial Infection Elimination
Origin Synthetic

Primol is a trade name for the powerful, synthetic anti-infective agent Ciprofloxacin. It is structurally classified as a fluoroquinolone antibiotic, specifically belonging to the second-generation subgroup of quinolones. The active ingredient, Ciprofloxacin, is often present as the hydrochloride salt, a single-ingredient compound that is manufactured in a laboratory, establishing its identity as a fully synthetic antimicrobial agent, not derived from natural sources. This modern chemical structure provides the characteristic efficacy that separates it from many older antibiotic types, and its role in treating significant bacterial illnesses is clinically recognized across multiple healthcare settings.

The core composition of this medicine is the active pharmaceutical ingredient Ciprofloxacin, combined with basic vehicle materials appropriate for its presentation. The drug is manufactured for administration across multiple routes, reflecting its application in treating infections throughout the body. The primary dosage forms available for systemic use include solid, oral preparations such as film-coated tablets, as well as liquid formulations like oral suspension and sterile solutions for intravenous injection. The versatility of Ciprofloxacin formulations is well-documented.

The general purpose of Ciprofloxacin is to serve as a potent bactericidal anti-infective agent, meaning it is specifically designed to rapidly kill susceptible bacteria rather than merely inhibiting their growth. Ciprofloxacin achieves this definitive action by disrupting the bacteria's vital genetic machinery. Its mechanism targets essential enzymes, bacterial DNA gyrase and Topoisomerase IV, which are necessary for the bacteria to accurately copy and repair their DNA. This highly specific biological activity ensures that the medicine delivers a decisive, broad-spectrum action against the cause of the infection.

What side effects are possible with Primol?

Possible Side Effects and Safety Information

The safety profile for Primol (Ciprofloxacin) is detailed in regulatory documents, identifying both common and serious adverse reactions across multiple body systems. The official labeling highlights potentially disabling and irreversible risks that necessitate immediate attention.

Serious and High-Priority Safety Warnings

Official government regulatory sources include a Boxed Warning for Ciprofloxacin, documenting disabling and potentially irreversible serious adverse reactions. These warnings include Tendinitis and Tendon Rupture (most frequently the Achilles tendon) and Peripheral Neuropathy (symptoms like pain, burning, tingling, or weakness). Serious Central Nervous System (CNS) effects, such as seizures, confusion, and psychosis, are also documented. Additionally, the label notes risks of Aortic Aneurysm and Dissection and Clostridioides difficile-Associated Diarrhea (CDAD).

Common Adverse Reactions and Organ Systems

The most commonly reported adverse reactions (mathbfge 1% incidence) listed in prescribing information include nausea, diarrhea, vomiting, and abnormalities in liver function tests. Adverse effects are formally categorized by System-Organ Class (SOC), predominantly affecting the following systems:

System-Organ Class Representative Effects
Musculoskeletal Tendon/Joint pain, Muscle weakness
Nervous System Headache, Dizziness, Peripheral Neuropathy
Gastrointestinal Nausea, Diarrhea, Vomiting

Safety Constraints and Special Populations

Immediate discontinuation of Primol is required at the first sign of tendon pain, peripheral neuropathy, rash, or CNS symptoms. The risk of Tendinitis and Tendon Rupture is officially noted to be increased in older adults and in patients concomitantly using corticosteroids. Use is contraindicated in patients with a history of hypersensitivity to fluoroquinolones. Serious reactions can occur within hours to weeks after starting treatment, and tendon rupture may occur even months after completion of therapy.

Overdose and Emergency Response

Primol Overdose and when to seek help

Overdose of Primol (Ciprofloxacin) is associated with an exacerbation of documented systemic effects, requiring immediate emergency medical attention as stated in official regulatory guidance.

Documented Manifestations and Severe Outcomes

Acute overdose may present with severe Central Nervous System (CNS) manifestations, including increased dizziness, tremor, confusion, and in serious cases, seizures or convulsions. Gastrointestinal disturbances, such as nausea and vomiting, are also documented. A key concern is the potential for crystalluria (crystal deposits in the urine), which can lead to acute reversible renal toxicity. Cardiac risks include the potential for QT interval prolongation, which may precipitate serious arrhythmias.

Required Emergency Actions and Management

Immediate medical help must be sought if an overdose is suspected or if severe symptoms, such as a seizure, occur. Regulators mandate that since no specific antidote is known for Ciprofloxacin overdose, management is strictly symptomatic and supportive. This includes procedures like gastric lavage or the use of activated charcoal to reduce drug absorption following recent oral ingestion, and maintaining adequate hydration to mitigate the risk of crystalluria. ECG monitoring and continuous monitoring of renal function are required due to the documented systemic risks. Patients with impaired renal function are noted to be at a heightened risk for toxicity.

Therapeutic Uses of Primol

What Primol Treats: Main Uses and Benefits

Primol is applied in therapeutic contexts that require effective symptomatic support and the moderation of acute physical discomfort. Its main use is to provide supportive relief in situations involving certain distressing symptoms. This medicine is commonly used to help with symptoms related to physical discomfort, pain, and systemic imbalance (fever). It contributes to improved day-to-day comfort during symptomatic periods and assists with maintaining functional stability.

The medication is relevant for managing symptoms that interfere with daily comfort and are associated with acute or episodic changes. It is applied in addressing symptom clusters that may become intense or disruptive, such as headache, muscle soreness, fever, and common cold symptoms.

“Applied across domains where additional symptomatic support is needed, this medicine is relevant for managing symptoms that interfere with daily comfort.”

Primol is relevant in conditions characterized by periods of heightened symptoms. It supports the patient during difficult episodes by easing distress and is commonly used when supportive symptom management is appropriate.

Quick Fact: Relief for Systemic Discomfort

Eligibility and Restrictions for Use

Primol (Ciprofloxacin) is an antibiotic whose use is governed by strict population-eligibility rules established in regulatory documents.

Contraindicated Populations

The medicine is formally contraindicated and must not be used in the following patient groups:

  • Patients with a known hypersensitivity or allergy to ciprofloxacin or any other quinolone or fluoroquinolone antibiotic.
  • Patients receiving the drug tizanidine (a muscle relaxant), due to a severe interaction that can increase tizanidine concentrations.
  • Patients with a known history of Myasthenia Gravis are advised to avoid use, as it may exacerbate muscle weakness.

Age-Related Eligibility and Restrictions

Age Group Eligibility Status (Regulatory Label)
Adults (18+ years) Generally approved for labeled systemic infections.
Pediatric Patients (Under 18) Restricted Use Only. Approved only for specific severe infections (e.g., Inhalational Anthrax, Plague, Complicated UTI) where the benefit clearly outweighs the risk.
Geriatric Patients (Over 60) Use with caution due to increased risk of severe tendon disorders.

Conditional Use and Comorbidities

Use is highly restricted for patients with certain pre-existing conditions:

  • Renal Impairment: Requires dosage adjustments based on the degree of kidney function reduction.
  • Cardiac Conditions: Avoid use in patients with known prolongation of the QT interval (a heart rhythm disorder).
  • Pregnancy and Lactation: Use during pregnancy is conditional; use during breastfeeding requires caution, as the drug is excreted into human milk.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Contraindicated and Restricted Combinations

Co-administration of Primol (Ciprofloxacin) is formally contraindicated with Tizanidine due to the officially documented risk of a significant increase in Tizanidine plasma concentrations. This interaction can lead to severe hypotensive and sedative effects. Regulatory authorities also apply restrictions to combinations with other medicines known to prolong the QT interval, such as certain Class IA and III antiarrhythmics, macrolide antibiotics, and tricyclic antidepressants, based on the risk of additive pharmacodynamic effects.

Pharmacokinetic and Clearance Interactions

Primol is an inhibitor of the CYP1A2 enzyme pathway, which can result in increased plasma exposure of co-administered substrates like Theophylline and Caffeine. This increase in systemic levels is a documented outcome. Furthermore, Primol interferes with the renal tubular transport of Methotrexate, leading to reduced clearance and increasing the risk of Methotrexate exposure.

Timing and Absorption Constraints

The absorption of Primol is significantly reduced by products containing polyvalent cations. This includes Antacids, Sucralfate, and mineral supplements (Iron, Zinc). To prevent this interaction, the regulatory label mandates that Primol must be taken at least two hours before or six hours after these cation-containing products. Taking Primol with milk, yogurt, or calcium-fortified beverages is also documented to reduce its oral availability.

Mechanism of Action

The effect of Ciprofloxacin (Primol) is a bactericidal (cell-killing) action achieved by interfering with the core genetic processes of susceptible bacteria.

Inhibition of Core Bacterial Genetic Enzymes

The mechanism begins by Ciprofloxacin targeting and inhibiting two vital bacterial Type II topoisomerases: DNA Gyrase (GyrA subunit) and Topoisomerase IV (ParC subunit). The drug acts as an enzyme poison, binding to and stabilizing the intermediate complex where the enzyme has cleaved the bacterial DNA, thereby blocking the essential process of resealing the DNA strand breaks.

Cascade of Lethal Genomic Damage

By inhibiting the resealing mechanism, Ciprofloxacin rapidly causes a massive accumulation of irreversible double-strand DNA breaks throughout the bacterial genome. This extensive genomic damage triggers the bacterial cell’s own SOS response, a self-destruction pathway that culminates in the rapid death of the bacterial cell.

Mechanism Constraints and Efficacy Factors

The rate of this bactericidal mechanism is inherently concentration-dependent (i.e., the kill rate increases with drug concentration at the target). The biological action is constrained by resistance mechanisms such as mutations in the target enzymes ( GyrA and ParC), or the overexpression of efflux pumps that actively expel the Ciprofloxacin molecule from the bacterial interior.

Dosage and Administration Information

How to Use Primol: Official Administration Guidelines

Primol (Ciprofloxacin) is administered according to strict protocols to ensure consistent application of the medicine's systemic and localized forms. Usage is specified across multiple official routes of administration, including oral (tablets, suspension, extended-release), intravenous (IV) infusion, and topical (eye/ear drops).


Official Usage Patterns

The dosing schedule is highly variable and dependent on the prescribed use, typically ranging from 250 mg to 750 mg per dose orally or 200 mg to 400 mg per dose intravenously. Immediate-release forms are most often scheduled for administration twice daily (q12h), while extended-release tablets are taken once daily. The duration of therapy is explicitly defined and may range from short-term courses of 3 to 14 days to prolonged treatment lasting up to 60 days for specific applications.


Administration Requirements and Adjustments

Oral administration can be done with or without food; however, a key constraint is the instruction to avoid taking the dose with dairy products or calcium-fortified juices alone, as this can significantly reduce absorption. Special handling instructions require that extended-release tablets must be swallowed whole and must not be crushed or chewed. IV solutions require slow delivery, administered over a 60-minute infusion time.

Mandatory dose adjustments are specified for patients with renal impairment (kidney function changes), with modifications to the dose amount or the dosing interval based on the patient’s creatinine clearance. Pediatric use is also governed by weight-based (mg/kg) dosing rules for specific indications.

Recent Clinical Evidence

Primol: Recent Clinical Evidence

Evidence for Use in Complicated Urinary Tract Infections and Severe Systemic Infections

Research into complicated urinary tract infections (cUTI), pyelonephritis, and severe lower respiratory tract infections (LRTIs) often involved Randomized Controlled Trials (RCTs) and systematic reviews. These studies explored how Primol was studied against other standard antibacterial agents. Primary research monitored both clinical outcomes (tracking symptom evolution) and pathogen outcomes (tracking the presence of bacteria) across the populations studied, which included adults and, in specific cases, critically ill patients. Comparative studies reported measurements related to survival and stability outcomes within the study cohorts.

Evidence for Use in Bone, Joint, and Complex Tissue Infections

Research related to deep tissue infections, such as osteomyelitis, requires long-term observational reviews due to the lengthy treatment courses involved. Studies monitored outcomes related to daily functioning and the durability of clinical measurements. For severe infections, the research describes that sustained resolution was monitored over periods of six months or more, though evidence quality varies across these observational studies.

Long-Term Studies and Durability of Response

Research has primarily tracked patient outcomes for only weeks or a few months after treatment has stopped. Data show patterns related to persistence or recurrence of infection within the observed time intervals. However, long-term effects are not fully established, and there is limited information regarding the durability of clinical measurements well beyond the immediate follow-up period documented in most trials.

Evidence in Special Populations and Areas of Uncertainty

Research has examined Primol in several special populations, including pediatric patients (often under specific regulatory protocols) and critically ill adults. The scientific literature points to several key limitations: comparative evidence is lacking for certain indications, and the global issue of Antimicrobial Resistance (AMR) means that data related to the susceptibility of Primol are subject to change.

Frequently Asked Questions (FAQ)

Common questions about Primol (FAQ)


Q: How quickly does Primol typically start working?

Official regulatory data indicates that maximum concentrations of Primol in the blood are usually achieved 1 to 2 hours after a patient takes an oral dose. The drug's mechanism of action involves a concentration-dependent effect, where the presence of the medicine at the site of infection is necessary for its action against bacteria.


Q: How long do the effects of Primol last?

Based on pharmacokinetic data from official sources, the drug's serum elimination half-life is typically around 4 to 6 hours for patients with normal kidney function. The half-life refers to the time it takes for the concentration of the drug in the body to decrease by half.


Q: Are there any food or drink restrictions while taking Primol?

Official documents advise against taking Primol with dairy products (like milk) or calcium-fortified juices alone, as this can significantly reduce the drug's absorption. The regulatory label specifies that products containing polyvalent cations, such as antacids or mineral supplements (Iron, Zinc), should be spaced at least two to six hours apart from the Primol dose.


Q: Are there any non-prescription medicines that interact with Primol?

Yes, official labeling includes warnings about certain products that can interfere with Primol’s absorption. Specifically, supplements and over-the-counter products that contain polyvalent cations, such as antacids or mineral supplements (like Iron or Zinc), must be spaced apart from the Primol dose.


Q: What happens if I stop taking Primol suddenly?

Official documents specify that the full prescribed course of Primol should be completed, even if symptoms improve, to ensure elimination of the targeted infection. Non-completion may compromise the full bactericidal action.


Q: Does the time of day matter when taking Primol?

The official administration schedules are defined as either once daily or twice daily, depending on the prescribed formulation. Official documentation describes the use of evenly spaced times to maintain consistent drug levels in the body.


Q: How does Primol interact with alcohol?

Regulatory warnings indicate that consuming alcohol may increase the risk and severity of certain side effects of Primol, such as dizziness or decreased alertness. The regulatory information describes the potential for increased side effects when combined with alcohol.


Q: What if I experience a mild side effect listed for Primol?

Official safety information documents the requirement for immediate discontinuation and professional consultation upon the appearance of signs of severe or serious adverse reactions, such as tendon pain, peripheral neuropathy, or skin rash. For common, mild side effects, official documentation provides reporting information but does not give specific clinical directions.


Q: Why are there different strengths or versions of Primol?

The official label specifies different strengths and various forms, such as oral tablets, IV solutions, and extended-release tablets. These variations are necessary to accommodate the varying treatment regimens and specific infection types listed in the indications.


Q: Is Primol considered a painkiller or something else?

According to official documentation, Primol (Ciprofloxacin) is classified as a synthetic, broad-spectrum fluoroquinolone antibiotic. Its general purpose is to kill susceptible bacteria, and it is not categorized as a painkiller.


Q: Is it normal to feel a bit dizzy after starting Primol?

Official labeling documents list dizziness as a commonly reported adverse reaction affecting the nervous system. The occurrence of dizziness is a documented observation in the safety profile of the medicine.


Q: Can Primol affect my ability to drive or operate machinery?

Official safety warnings state that Primol may cause effects such as dizziness, lightheadedness, or decreased alertness. Official warnings note that the patient's coordination, reaction time, or judgment may be affected by the medicine's side effects.


Q: Is Primol safe for women who are planning pregnancy?

Official safety information does not contain specific data regarding the pre-conception or planning stage. However, use during established pregnancy is conditional and based on a risk-benefit assessment, as noted in the regulatory documents.


Q: Why do people feel tired when they first start Primol?

While fatigue or tiredness is not listed among the most common adverse reactions, regulatory documents do include other effects on the nervous system, such as headache and dizziness. These nervous system effects are documented in the official safety profile.


Q: What is the primary mechanism that prevents certain people from using Primol?

Official documents state that Primol is formally contraindicated, meaning it must not be used, in certain patient groups. These groups include those with a known hypersensitivity to fluoroquinolones, patients taking the drug Tizanidine, and those with a history of Myasthenia Gravis.


Q: Has Primol been studied in children or adolescents?

Regulatory information indicates that use in pediatric patients (under 18) is restricted but approved for specific, severe infections, such as those related to anthrax or complicated urinary tract infections. The official label includes specific weight-based dosing guidelines for these authorized indications.


Q: What should I know about Primol's storage instructions?

Official guidelines state that the product should be kept in its original packaging at standard room temperature. Regulatory documents state that the medicine should be stored out of the reach of children.


Q: Can I crush or split Primol tablets?

Regulatory instructions specify that the extended-release tablet formulation is intended to be swallowed whole and should not be crushed, split, or chewed. This is necessary to maintain the proper release of the medicine in the body.


Q: Is Primol a controlled substance?

According to official drug classifications, Primol (Ciprofloxacin) is classified as a prescription medicine but is not listed as a controlled substance by regulatory bodies.


Q: Do I need regular blood tests while I am taking Primol?

Official information notes that dose adjustments are mandated for patients with reduced kidney function. Due to potential abnormalities in liver function tests, some regulatory documents advise for blood work checks during long-term treatment.


Q: Is Primol still effective if I take it with milk?

Official documents advise against taking Primol with milk or other calcium-fortified beverages because they significantly reduce the drug's oral absorption and availability. Reduced availability means less of the active ingredient reaches the site of action.


Q: Is it true that Primol is only for short-term use?

The official duration of therapy for Primol varies widely, depending on the specific infection being treated. Treatment may range from short courses of a few days up to prolonged periods of 60 days for certain serious applications.


Q: How is the safety of Primol monitored after it has been approved?

Regulatory authorities require ongoing post-marketing surveillance to monitor the medicine's safety profile once it is available to the public. This process is designed to detect previously unknown risks and collect real-life data on adverse reactions.


Q: Are there any specific official warnings about using Primol?

Yes, official government labeling includes a Boxed Warning, which is the strongest warning required by regulation. This warning details potentially disabling and irreversible serious adverse reactions, such as Tendinitis, Tendon Rupture, and Peripheral Neuropathy.


Q: Is there a link between Primol and mental health changes?

Official warnings document the risk of serious Central Nervous System (CNS) effects. These effects include confusion, psychosis, and in rare cases, depression and suicidal ideation, which regulatory documents note may occur even after the first dose.


Q: Does Primol change how other medicines are absorbed?

Official documents state that Primol can interfere with certain liver enzyme systems (specifically the CYP1A2 pathway). This interference may lead to increased systemic exposure of other medicines that are cleared by that pathway, such as Theophylline or Caffeine.


Q: What are the typical benefits of taking Primol as described in studies?

Studies described in official literature typically focus on monitoring clinical outcomes (tracking the resolution of symptoms) and pathogen outcomes (documenting the elimination of susceptible bacteria). Measurements related to patient survival and stability in complex infections are also tracked.

How should Primol be stored and disposed of?

The official storage and disposal guidelines for this medicine (Norethisterone, commonly marketed as Primolut N) are defined in government regulatory documents to ensure product stability and safety.

Official Storage & Stability

Requirement Official Statement/Classification
Shelf-Life 5 years
Temperature Standard room temperature (implied)
Protection Supplied in aluminium/PVC blisters in a carton

Handling and Disposal

Regulatory labeling mandates that the product must be kept out of the reach of children. The solid tablet form is protected by its original blister and carton packaging. Once the medicine is expired or no longer needed, it must be disposed of according to local pharmaceutical waste regulations. This ensures the medicine is handled safely and is properly removed from the household environment.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Primol found in:

A-Z Index: